Robert W. Baird Has Lowered Expectations for Intuitive Surgical (NASDAQ:ISRG) Stock Price

Intuitive Surgical (NASDAQ:ISRG) had its price target decreased by analysts at Robert W. Baird from $707.00 to $600.00 in a report issued on Tuesday,Benzinga reports. The firm presently has an “outperform” rating on the medical equipment provider’s stock. Robert W. Baird’s price objective would suggest a potential upside of 22.75% from the stock’s current price.

A number of other research firms have also weighed in on ISRG. Jefferies Financial Group raised their target price on shares of Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. Bernstein Bank boosted their price objective on Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a report on Monday, January 27th. Royal Bank of Canada raised their target price on Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. Citigroup boosted their price target on Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a report on Friday, January 24th. Finally, JPMorgan Chase & Co. increased their price target on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have issued a buy rating to the company. Based on data from MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average price target of $611.86.

Intuitive Surgical Stock Up 0.9 %

Shares of NASDAQ ISRG opened at $488.80 on Tuesday. Intuitive Surgical has a 52 week low of $364.17 and a 52 week high of $616.00. The business’s 50 day moving average price is $566.38 and its 200 day moving average price is $531.96. The firm has a market cap of $174.10 billion, a P/E ratio of 76.26, a P/E/G ratio of 5.85 and a beta of 1.43.

Insider Buying and Selling at Intuitive Surgical

In related news, EVP Robert Desantis sold 11,545 shares of the company’s stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the completion of the sale, the executive vice president now owns 5,224 shares of the company’s stock, valued at approximately $2,607,925.28. This represents a 68.85 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CFO Jamie Samath sold 269 shares of the firm’s stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $590.00, for a total transaction of $158,710.00. Following the sale, the chief financial officer now owns 3,282 shares of the company’s stock, valued at $1,936,380. This represents a 7.58 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 33,754 shares of company stock worth $17,691,621. Insiders own 0.90% of the company’s stock.

Institutional Trading of Intuitive Surgical

Several institutional investors and hedge funds have recently bought and sold shares of ISRG. Howard Capital Management Group LLC boosted its position in shares of Intuitive Surgical by 4.5% during the 3rd quarter. Howard Capital Management Group LLC now owns 2,125 shares of the medical equipment provider’s stock worth $1,044,000 after purchasing an additional 92 shares during the period. Principal Financial Group Inc. boosted its position in shares of Intuitive Surgical by 1.5% during the third quarter. Principal Financial Group Inc. now owns 602,393 shares of the medical equipment provider’s stock worth $295,938,000 after buying an additional 9,194 shares during the period. Quest Partners LLC purchased a new position in shares of Intuitive Surgical during the third quarter worth $173,000. MidAtlantic Capital Management Inc. acquired a new stake in shares of Intuitive Surgical in the third quarter valued at $33,000. Finally, Pathstone Holdings LLC raised its holdings in shares of Intuitive Surgical by 2.6% in the 3rd quarter. Pathstone Holdings LLC now owns 48,928 shares of the medical equipment provider’s stock valued at $24,037,000 after buying an additional 1,228 shares during the period. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.